Yahoo!
My Yahoo!
Mail
Sign In
[New User?
Sign Up
]
Finance Home
|
Help
Wednesday, February 10, 2010, 6:21am EST - Canadian Markets open in 3 hours and 9 minutes.
To create a watchlist or portfolio of shares,
Sign-in
or
Register
Finance Home
Investing
Volume Leaders
Local Markets
US Markets
International Markets
Advances & Declines
ETFs
Income Trust News
News & Opinion
Markets
Industry
RSS-My Yahoo!
Personal Finance
Banking & Budgeting
Calculators
Insurance
Retirement
Taxes
My Portfolios
Sign In to Create/Edit My Portfolios
Get Quotes
Symbol Lookup
Exchanges
GeneLink Inc. (GNLK.OB)
On Feb 9:
0.13 USD
0.00 (0.00%)
MORE ON GNLK.OB
Quotes
Summary
Options
Historical Prices
Charts
Interactive
Basic Chart
Technical Chart
News & Info
Headlines
Company Events
Company
Profile
Key Statistics
SEC Filings
Competitors
Industry
Analyst Coverage
Analyst Opinion
Analyst Estimates
Research Reports
Star Analysts
Ownership
Major Holders
Insider Trans.
Insider Roster
Financials
Income Statement
Balance Sheets
Cash Flow
GENELINK INC
(OTC BB:GNLK.OB) Delayed quote data
Last Trade:
0.13 USD
Trade Time:
Feb 9
Change:
0.00 (0.00%)
Prev Close:
0.13
Open:
N/A
Bid:
N/A
Ask:
N/A
1y Target Est:
N/A
Day's Range:
N/A - N/A
52wk Range:
0.06 - 0.19
Volume:
0
Avg Vol
(3m)
:
79,349.2
Market Cap:
14.39M
P/E
(ttm)
:
N/A
EPS
(ttm)
:
-0.02
Div & Yield:
N/A (N/A%)
1d
5d
3m
6m
1y
2y
5y
max
Add GNLK.OB to Portfolio
Download Data
HEADLINES
GENELINK INC Financials
EDGAR Online Financials
(Sat, Feb 6)
GENELINK INC Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online
(Mon, Feb 1)
GENELINK INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
EDGAR Online
(Mon, Dec 28)
David L. Macdonald Appointed CEO of GeneLink BioSciences, Inc.
PRNewswire
(Mon, Dec 28)
GeneLink Reports Third Quarter Results
Business Wire
(Mon, Nov 16)
GENELINK INC Files SEC form 10-Q, Quarterly Report
EDGAR Online
(Fri, Nov 13)
GENELINK INC Files SEC form 10-K/A, Annual Report
EDGAR Online
(Thu, Nov 5)
GENELINK INC Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online
(Mon, Oct 5)
GENELINK INC Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online
(Wed, Aug 19)
GENELINK INC Files SEC form 8-K, Other Events
EDGAR Online
(Thu, Aug 13)
More Headlines for GNLK.OB...
ANALYST
EPS Est (next year)
(Dec-69)
:
N/A
EPS Est (in 2 years)
(Dec-69)
:
N/A
Avg Rec (current)*:
N/A
PEG Ratio:
N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion
-
Estimates
BUSINESS SUMMARY
GeneLink, Inc., through its subsidiaries, operates as a biosciences company that provides genetically-guided health, beauty, and wellness products to nutraceutical, personal care, and skin care industries in the United States.
Full Company Profile
Add to Portfolio
Email to a Friend
Get
Summary
for Another Symbol:
Symbol Lookup
Latest News
Canadian Indices